课题基金 / 基金详情

T CELL RECEPTOR COUPLED SIGNALING AND APOPTOSIS

T CELL RECEPTOR COUPLED SIGNALING AND APOPTOSIS
T 细胞受体偶联信号传导和细胞凋亡
批准号:
6235317
负责人:
HARVEY CANTOR
金额:
$20.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-06-01 至 1998-05-31

项目摘要

项目成果

HARVEY CANTOR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have recently obtained evidence for a novel signalling pathway coupled to TCR ligation by MTV superantigen an high concentrations of peptide which leads to transient activation and apoptosis. This signalling cascade may be associated with MAP2 kinase-dependent activation of phospholipase A2 (PLA2) and lipoxygenase which in turn catalyzes the generation of reactive oxygen intermediates (R01s). We also outline evidence suggesting that this pathway may regulate gene expression via activation of th p50/52 component of the NF-kB complex. In Specific Aim 1, we propose experiments to systematically define the kinetics of phospholipase A2 (PLA2) activation of HPETE and release of hydroxyl radicals (OH). In Specific Aim 2, we propose to define the proximal events which couple the TCR to PLA2 activation. This will include an initial assessment of the role of MAP-2 kinase in PLA2 activation, followed by experimental analysis of the potential roles of p21 Ras-dependent pathways that may connect these events with TCR ligation. Delineation of this pathway will allow us to map the interaction between this pathway and CD28-dependent signals which inhibit the apoptotic response following TCR ligation. In Specific Aim 3, we propose experiments to further define the distal biochemical events which may result in activation of NF-kB. In Specific Aim 4, we will determine whether generation of hydroxyl radicals is necessary and sufficient for T-cell apoptosis or whether these represent intermediates in a signalling pathway which results in transcriptional activation of gene products responsible for cell death.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunologic mechanisms that prevent autoimmunity
  • 批准号:
    10265652
  • 项目类别:
  • 资助金额:
    $40.78万
  • 财政年份:
    2020
  • 负责人:
    HARVEY CANTOR
  • 依托单位:
THE T-CELL RESPONSE TO ANTIGEN
  • 批准号:
    6374616
  • 项目类别:
  • 资助金额:
    $27.37万
  • 财政年份:
    2000
  • 负责人:
    HARVEY CANTOR
  • 依托单位:
Regulation of the follicular T-cell response to autoimmunity
  • 批准号:
    10066305
  • 项目类别:
  • 资助金额:
    $42.95万
  • 财政年份:
    2000
  • 负责人:
    HARVEY CANTOR
  • 依托单位:
THE T-CELL RESPONSE TO ANTIGEN
  • 批准号:
    6511531
  • 项目类别:
  • 资助金额:
    $28.12万
  • 财政年份:
    2000
  • 负责人:
    HARVEY CANTOR
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: